Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InspireMD (NSPR) EPS (Weighted Average and Diluted) (2022 - 2025)

InspireMD (NSPR) has 4 years of EPS (Weighted Average and Diluted) data on record, last reported at -$0.16 in Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) changed 0.0% year-over-year to -$0.16; the TTM value through Sep 2025 reached -$0.82, down 13.89%, while the annual FY2024 figure was -$0.76, 7.32% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.16 in Q3 2025 per NSPR's latest filing, up from -$0.26 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.05 in Q3 2023 and bottomed at -$0.61 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$0.3, with a median of -$0.22 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 91.38% in 2023, then tumbled 220.0% in 2024.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.61 in 2022, then surged by 78.76% to -$0.13 in 2023, then tumbled by 38.46% to -$0.18 in 2024, then rose by 11.11% to -$0.16 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were -$0.16 in Q3 2025, -$0.26 in Q2 2025, and -$0.22 in Q1 2025.